First IPO Application Accepted under the Reinstated Fifth Set of STAR Market Listing Standards

Translated from Securities Times, Zhang Shuxian

July 31 - People's Financial News. On July 31, the Shanghai Stock Exchange (SSE) accepted the STAR Market IPO application of Zhuhai Trinomab Biopharmaceutical Co., Ltd. (referred to as "Trinomab"), making it the first company to be successfully accepted under the reinstated fifth set of STAR Market listing standards. Trinomab is an innovative biopharmaceutical company founded in 2015. According to its prospectus, the company has secured investment from senior professional institutional investors.